Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 20, 2025 08:00 ET | Source: Medidata Solutions, Inc.

Caidya Reimagines Next Generation Clinical Trial Innovation and Study Delivery with Medidata AI-Powered Experiences

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that Caidya, a leading...
November 12, 2025 09:00 ET | Source: Zarminali Pediatrics

All Better Pediatrics is Now Part of Zarminali Pediatrics, Bringing Future of Care to Tennessee Families

MEMPHIS, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Zarminali Pediatrics, the first outpatient pediatric destination purpose-built to provide elevated, seamlessly coordinated primary and specialty care...
November 10, 2025 12:48 ET | Source: Lice Busters

Lice Busters Launches NYC School Partnership Program to Combat Rising Lice Epidemic

BROOKLYN, N.Y., Nov. 10, 2025 (GLOBE NEWSWIRE) -- When classrooms reopened after the pandemic, parents expected the usual coughs, colds, and homework battles. What no one expected was the quiet...
October 27, 2025 11:14 ET | Source: Research and Markets

United States Pediatrics KOLs Fair-Market Value Compensation Rates Report 2025: An Independent Reference for Negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs)

Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "Fair-Market Value Compensation Rates for Pediatrics KOLs - United States" report has been added to ResearchAndMarkets.com's offering. Thought Leader...
October 13, 2025 08:05 ET | Source: MannKind

MannKind Announces U.S. FDA Accepts for Review its Supplemental Biologics License Application (sBLA) for Inhaled Insulin (Afrezza) in Children and Adolescents Aged 4-17 Years Living with Diabetes

MannKind Announces U.S. FDA Accepts for Review its sBLA for Inhaled Insulin in Children and Adolescents Aged 4-17
September 30, 2025 08:45 ET | Source: Nuwellis, Inc.

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

ULTRA-Peds Registry Demonstrate 92% Treatment Survival in Children with AKI Fluid Overload or Congenital Kidney Failure
September 17, 2025 10:16 ET | Source: Nuwellis, Inc.

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Watch the “What This Means” segment here MINNEAPOLIS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for...
September 03, 2025 13:47 ET | Source: Tiny Health

New Study: Gut Health Program Cuts Infant Eczema Odds by 83% in C-Section Babies

AUSTIN, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- A new study found that babies born by C-section had 83% lower odds of developing eczema when their families participated in a 6-month gut health...
August 28, 2025 08:10 ET | Source: Seluna Ltd

Scottish Medtech Seluna Launches Pediatric Sleep Trial Ahead of U.S. Entry

Glasgow, UK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Scottish Medtech Seluna Launches Pediatric Sleep Trial Ahead of U.S. Entry Seluna seeks US collaborations and investment to transform childhood...
August 05, 2025 09:00 ET | Source: Zarminali Pediatrics

Zarminali Pediatrics Expands Clinical Leadership with Chief Medical Officer, Continues Network Growth Throughout United States

CHICAGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Zarminali Pediatrics, the first outpatient pediatric destination purpose-built to provide elevated, seamlessly coordinated primary and specialty care...